Consumer

"Top regulatory officials met with agricultural and chemical industry representatives dozens of times in the first few months after President Donald Trump took office in January, government records show — meetings that were followed by a series of regulatory rollbacks and a downplaying of pesticide concerns by the administration’s “Make America Healthy Again” (MAHA) Commission."

"Smoke from wildfires exacerbated by climate change may cause as many as 71,000 additional deaths per year in the United States by 2050, a study published Thursday in the journal Nature found."

"The Trump administration has axed nearly two dozen projects addressing health and environmental issues in Southern Black communities, a Washington Post analysis found, reversing years of work to address pollution, sewage leaks, flooding and more."

"The provision in the government funding bill could shield pesticide companies from billions of dollars in lawsuits."

"America’s cancer research system, which has helped save millions of lives, is under threat in one of its most productive moments."

"A recent study has revealed that the majority of shark meat available to American shoppers is mislabeled, with much of it coming from endangered species."

"A growing population, leaking pipes and changing climate threaten the state’s water supply. Texas lawmakers hope a $20 billion investment will help."

"In the most remote parts of Alaska, staying in touch can involve a bit more effort than sending a text. Cell service is spotty, highways are nonexistent, and the postal service remains a vital lifeline, delivering supplies and mail by plane. But for anyone who wants to broadcast a different kind of message — a reminder to pick up milk, for example, or birthday wishes — there’s always the Muktuk Telegram."

"A group of experts says Western states urgently need to cut water use to avert a deepening crisis on the Colorado River. The river’s major reservoirs are less than one-third full, and another dry winter would push reservoirs toward critically low levels."

"FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny."